Ayala Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ayala Pharmaceuticals generated cash of -$34,510,000, which is more than the previous year. Cash used in financing activities reached the amount of -$103,000 last year. Net change in cash is therefore -$34,615,000.
Cash Flow
| 2018 | -6.37M | -250K | 25.42M |
|---|---|---|---|
| 2019 | -14.95M | -1.58M | 7.07M |
| 2020 | -27.54M | 181K | 52.92M |
| 2021 | -38.35M | -5K | 33.33M |
| 2022 | -34.51M | -2K | -103K |
AYLA Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 37.33M | 42.37M | 16.80M | 26.26M | 7.46M |
Operating activities | |||||
Net income | -38.01M | -40.25M | -30.14M | -17.79M | -8.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 162K | 168K | 182K | 150K | 49K |
Stock-based compensation expense | 2.24M | 2.68M | 1.56M | 727K | 1.06M |
| Deferred income tax benefit | 2.24M | 2.68M | 1.56M | 727K | 1.06M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -234K | 681K | -212K | -469K | 0 |
Inventories | 0 | 0 | -36.74M | 200K | 0 |
Accounts payable | -181K | 51K | 451K | 1.93M | 818K |
Cash generated by operating activities | -34.51M | -38.35M | -27.54M | -14.95M | -6.37M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2K | -5K | -45K | -1.33M | -221K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2K | -5K | 181K | -1.58M | -250K |
Financing activities | |||||
Common Stock Issued | 512K | 0 | 52.64M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -209K | 0 | 0 | 0 |
Cash used in financing activities | -103K | 33.33M | 52.92M | 7.07M | 25.42M |
Net Change In Cash | -34.61M | -5.03M | 25.56M | -9.45M | 18.79M |
Cash at end of period | 2.72M | 37.33M | 42.37M | 16.80M | 26.26M |
| Data source | Data source | Data source |